Nutrien Ltd.

Report azionario TSX:NTR

Capitalizzazione di mercato: CA$50.6b

Nutrien Performance degli utili passati

Criteri Il passato verificati 4/6

Gli utili di Nutrien sono diminuiti a un tasso medio annuo di -14.5%, mentre il settore Chemicals ha visto gli utili crescere a un tasso medio annuo di 12.4%. I ricavi sono cresciuti crescere a un tasso medio annuo di 0.3%. Il ritorno sul capitale proprio di Nutrien è 9.1% e ha margini netti di 8.7%.

Informazioni chiave

-14.52%

Tasso di crescita degli utili

-12.05%

Tasso di crescita dell'EPS

Chemicals Crescita del settore4.55%
Tasso di crescita dei ricavi0.35%
Rendimento del capitale proprio9.06%
Margine netto8.74%
Prossimo aggiornamento sugli utili07 May 2026

Aggiornamenti sulle prestazioni recenti

Recent updates

Aggiornamento dell'analisi May 03

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Future Returns

The updated analyst price target for Nutrien reflects a small decrease of about CA$0.26. Analysts are balancing slightly softer implied revenue growth and a marginally higher discount rate against firmer profit margin assumptions and a modestly lower future P/E multiple.
Aggiornamento dell'analisi Apr 19

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has risen by CA$4.18. Analysts attribute this change to updated assumptions for slightly stronger revenue growth, higher profit margins, and a lower future P/E multiple, reflecting the recent wave of higher sector targets and tighter global fertilizer markets.
Aggiornamento dell'analisi Apr 04

NTR: Tighter Fertilizer Markets And DOJ Probe Will Pressure Future Returns

Analysts have nudged the fair value estimate for Nutrien higher to CA$95.41. This reflects a modestly lower discount rate, slightly firmer long term margin assumptions, and updated sector P/E comparisons that incorporate a wave of recent price target increases tied to tighter fertilizer markets and higher commodity pricing expectations.
Aggiornamento dell'analisi Mar 21

NTR: Higher Fertilizer Pricing And DOJ Probe Will Shape Share Performance

Analysts have lifted the average Nutrien price target by roughly CA$31 to around CA$95, citing stronger fertilizer pricing, higher expected profit margins and support for elevated sector valuation multiples, despite more cautious views on volume growth. Analyst Commentary Recent research on Nutrien largely centers on fertilizer pricing, geopolitical risks and the earnings impact of tighter nitrogen and potash markets.
Aggiornamento dell'analisi Mar 07

NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation. Analyst Commentary Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation.
Aggiornamento dell'analisi Feb 21

NTR: Firmer Nutrient Pricing And Potash Supply Risks Will Shape Balanced Returns

Our updated fair value estimate for Nutrien edges higher to CA$96.56 from CA$91.99, reflecting a series of analyst price target increases tied to refreshed models after recent results, stronger assumed profit margins, and expectations that nutrient pricing holds firmer for longer, even as some remain cautious about future potash supply. Analyst Commentary Street research on Nutrien has been active, with several firms revisiting their models and adjusting price targets around recent and upcoming quarterly results.
Aggiornamento dell'analisi Feb 07

NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple. Analyst Commentary Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds.
Aggiornamento dell'analisi Jan 23

NTR: Higher Fertilizer Pricing And Buybacks Will Support Future Upside

Our analyst price target for Nutrien edges slightly lower to about $112.49 from $113.03, as analysts weigh mixed sector commentary on fertilizer and agriculture markets against recent target adjustments and an updated future P/E assumption of roughly 20.2x. Analyst Commentary Recent Street research on Nutrien reflects mixed sector views but a generally supportive tone on the company, with several bullish analysts adjusting targets and ratings while acknowledging a more cautious backdrop for fertilizers and agriculture.
Aggiornamento dell'analisi Jan 09

NTR: Fertilizer Cycle Concerns Will Pressure Shares Despite Recent Buybacks

Narrative Update Analysts have nudged their consolidated price target for Nutrien down by about $2 to $64. This reflects updated views that factor in more cautious fertilizer and agriculture setups, modestly lower assumed revenue growth, a slightly higher profit margin profile, and a reduced future P/E multiple in their models.
Aggiornamento dell'analisi Dec 21

NTR Is Expected To Benefit From Potential Upside In Fertilizer Pricing

Analysts have modestly reduced their price target on Nutrien to approximately $113 from about $97, citing a tougher near term backdrop for farmers, slightly lower growth and margin expectations, and a more balanced risk reward profile after the stock's strong run. Analyst Commentary Recent Street research reflects a mixed but generally constructive stance on Nutrien, with several firms trimming price targets modestly while maintaining positive ratings.
Aggiornamento dell'analisi Dec 07

NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution. Analyst Commentary Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.
Aggiornamento dell'analisi Nov 23

NTR: Portfolio Streamlining And Asset Sales Will Drive Sector Outperformance Ahead

Nutrien's analyst price target has been modestly reduced by $0.21 to $88.43. Analysts cite ongoing sector headwinds, including weaker crop prices, portfolio adjustments, and a more balanced risk-reward outlook, despite solid recent performance.
Aggiornamento dell'analisi Nov 07

NTR: Portfolio Streamlining and Supply Tightness Will Shape Upside Amid Sector Scrutiny

Nutrien’s average analyst price target has edged slightly lower in recent weeks, as analysts weigh a modestly improving profit margin and fair value estimate against easing revenue growth and persistent caution over the agricultural cycle. Analyst Commentary Recent analyst activity around Nutrien highlights both opportunities and challenges for the company as it navigates ongoing market volatility and shifting sector dynamics.
Aggiornamento dell'analisi Oct 24

Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty

Nutrien's analyst price targets have recently edged lower by $1 to $2 per share, as analysts cite cautious earnings expectations, a more balanced risk-reward profile, and the impact of portfolio adjustments on future performance. Analyst Commentary Recent Street research highlights a divided outlook among analysts covering Nutrien, reflecting both positive and cautionary perspectives as the company navigates its next phase of growth and portfolio transformation.
Aggiornamento dell'analisi Oct 09

Global Food Demand And Precision Ag Will Secure Fertilizer Success

Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions. Analyst Commentary Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity.
Articolo di analisi Sep 08

With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For

Nutrien Ltd.'s ( TSE:NTR ) price-to-earnings (or "P/E") ratio of 20.1x might make it look like a sell right now...
Articolo di analisi Aug 08

Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Shareholders might have noticed that Nutrien Ltd. ( TSE:NTR ) filed its second-quarter result this time last week. The...
Articolo di analisi Jul 16

Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
Articolo di analisi Jul 03

A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Nutrien fair value estimate is CA$98.09 Current share price of...
Articolo di analisi May 09

Nutrien Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nutrien Ltd. ( TSE:NTR ) just released its latest first-quarter report and things are not looking great. It wasn't a...
User avatar
Nuova analisi Feb 09

Accelerated Efficiency And Expanded Potash And Nitrogen Output Will Strengthen Future Operations

Accelerated operational efficiency and strategic sales expansion may enhance margins and boost revenue without significant new capital expenditure.

Ripartizione dei ricavi e delle spese

Come Nutrien guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storico di utili e ricavi

TSX:NTR Ricavi, spese e utili (USD Millions )
DataRicaviUtiliSpese G+ASpese di R&S
31 Dec 2525,9492,2674,0870
30 Sep 2525,6711,8094,0800
30 Jun 2525,0211,3634,0900
31 Mar 2524,7395274,1180
31 Dec 2425,0166744,1210
30 Sep 2425,5567334,2070
30 Jun 2425,8397904,2220
31 Mar 2427,3258454,1180
31 Dec 2328,0821,2584,0940
30 Sep 2329,9672,1983,9490
30 Jun 2332,5833,7003,9590
31 Mar 2335,4666,8533,9920
31 Dec 2237,0127,6604,0500
30 Sep 2236,7927,7494,1800
30 Jun 2234,6126,8894,1010
31 Mar 2229,8684,4044,0150
31 Dec 2126,8613,1533,8260
30 Sep 2123,6422,2683,6630
30 Jun 2121,8619643,5520
31 Mar 2120,5146213,4090
31 Dec 2020,0534593,3240
30 Sep 2019,534953,2130
30 Jun 2019,4708233,0840
31 Mar 2019,7549163,0520
31 Dec 1919,3169923,0280
30 Sep 1919,6711,3362,8890
30 Jun 1919,4491282,9290
31 Mar 1918,862112,9300
31 Dec 1818,772-312,8910
30 Sep 1816,051-4472,2980
30 Jun 1813,3766361,6310
31 Mar 186,489478290
31 Dec 174,0101542330
30 Sep 173,9731962180
30 Jun 173,8932612210
31 Mar 173,8242302330
31 Dec 163,9211992310
30 Sep 164,2394782530
30 Jun 164,6586792460
31 Mar 165,3309752510
31 Dec 155,7911,1152580
30 Sep 156,3031,4762580
30 Jun 156,4021,5112550

Guadagni di qualità: NTR ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di NTR (8.7%) NTR sono più alti rispetto allo scorso anno (2.7%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di NTR sono diminuiti del 14.5% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di NTR nell'ultimo anno ( 236.4% ) supera la media quinquennale ( -14.5% all'anno).

Guadagni vs Settore: La crescita degli utili NTR nell'ultimo anno ( 236.4% ) ha superato la percentuale del settore Chemicals 3.5%.


Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 9.1% ) di NTR è considerato basso.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/05/06 13:20
Prezzo dell'azione a fine giornata2026/05/06 00:00
Utili2025/12/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Nutrien Ltd. è coperta da 52 analisti. 15 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Harriet LiAccountability Research Corporation
Keith CarpenterATB Cormark
Benjamin TheurerBarclays